A new CPT® code set took effect January 1, 2026. This new code set includes modifications to the CPT coding for remote physiologic monitoring, remote therapeutic monitoring, and additions, deletions, and modifications pertinent to care of the lower extremity. These changes are shared here.
On this episode of SPS Unpacked, we’re exploring the PROTEOR Kinterra EVAQ8, a prosthetic foot designed to combine hydraulic ankle articulation with elevated vacuum suspension, delivering superior adaptability, comfort, and socket security for active users.
Many EHR systems include templates that outline the documentation requirements set by CMS for dispensing diabetic shoes in your office. However, unless vetted by a compliance specialist or created by someone who has experienced an insurance audit, small details may be overlooked.
On October 31, 2025, CMS released its “CY 2026 Medicare Physician Fee Schedule Final Rule.”1 This Rule finalized a new payment model for skin substitute products applied to Medicare Part B beneficiaries during a covered application procedure in a non-facility setting and in the hospital outpatient department setting.
Technology and AI are everywhere, promising to make your life easier by automating repetitive tasks. However, for many medical practices, the sheer number of tools and options can lead to decision paralysis. Where should you even begin?
Many procedures have either a 10- or 90-day postoperative global period. Generally, any care provided within that period is included in the payment for the procedure. However, there are some exceptions. If a patient in a postoperative global period experiences a complication of the procedure for which they are in the global period and an evaluation and management (E&M) of that complication is performed, there is no modifier that allows for submission of that E&M. The only E&M modifier that can be used during a postoperative global period is the 24 Modifier which is only appropriate when an E&M service is performed for a problem unrelated to the procedure for which the patient is in the postoperative global period.
All seven Part B Medicare Administrative Contractors have finalized new, identical coverage policies that will govern the application of skin substitutes/cellular and tissue-based products applied to diabetic foot ulcers and venous leg ulcers for Medicare Part B beneficiaries. These policies only rigidly apply to diabetic foot ulcers and venous leg ulcers. These policies take effect January 1, 2026.
Adding in-house X-ray sounds great until you realize it means costly equipment, radiation shielding, and room you don’t have. For podiatry, orthopedic, and dental offices, those limitations can quickly turn opportunity into obstacle.
Mobile and handheld X-ray offers a smarter, scalable alternative—so you get high-quality imaging without disrupting your space or straining your budget. SureFit provides a full line of solutions designed to fit real-world practices.
